|
|
|
|
Vaccine cocktail might be more effective against certain cancers
Researchers are giving vaccines in combination with other drugs either to help boost the immune response or to attack the cancer on multiple fronts.Even if a vaccine produces an appropriate cancer-attacking immune response, it still may...
|
|
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
Background.A 58-year-old man who had a 35-year history of Crohn's disease presented to our IBD center with a disease flare, pararectal fistulas and abscess formation. The patient had previously undergone ileocolic resection for a...
Nature Reviews Gastroenterology & Hepatology:
Jul 3 2009 11:37AM
Matching: lymphoma cell
|
Find similar documents
|
|
|
|
Flu Shot Doubles Cancer Risk In New Study
Getting a flu shot almost doubles the chance of getting cancer according to Lankes and colleagues.In a new study at the Feinberg School of Medicine of Northwestern University, Lankes found that a single flu shot at any time alters the...
|
|
|
Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize
- Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation.She is being honored with the prestigious international award for discoveries of...
|
|
|
Patients with extensive limb disease have worse pcALCL prognosis
MedWire News: Patients with primary cutaneous anaplastic large cell lymphoma (pcALCL) and extensive limb disease (ELD) have a more aggressive disease course and a differential gene expression profile to other patients with the...
|
|
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
_ Hepatosplenic T-cell lymphoma in a patient with Crohn's disease.
Nature Clinical Practice Gastroenterology & Hepato:
Jul 3 2009 10:08AM
Matching: lymphoma cell
|
Find similar documents
|
|
|
|
Stem Cell Possibilities Energize the Market
click to enlarge Estimated R&D expenditures Stem cells are the biological building blocks that form other cells in the body.Because of their universality and ability to replace or repair damaged tissue, the therapeutic...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company,...
|
|
|
Leukemia & Lymphoma Society Recognizes Aurora Physician as Man of the Year
MILWAUKEE, July 1 /PRNewswire/ -- Robert Taylor, M.D., was named Man of the Year by the Wisconsin Chapter of the Leukemia & Lymphoma Society.He received the honor at an awards ceremony Friday, June 26, at the Milwaukee...
|
|
|
NHL Less Deadly in Modern HIV Treatment Era
Two-thirds of HIV-positive individuals with non-Hodgkins lymphoma are alive a year after its diagnosis, European investigators report in a study published in the online edition of AIDS.A low nadir CD4 cell count was associated...
|
|
|
$500,000 Gruber Genetics Prize Awarded To Cancer Geneticist Janet Davison Rowley
Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics and a renowned leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation.She is being honored with the...
|
|
|
Janet Rowley awarded Gruber Genetics Prize for cancer research
Janet Rowley, a founder in the field of cancer cytogenetics and a leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation for her research on recurrent chromosomal abnormalities in...
|
|
|
Patients with certain blood cancers eligible for Quick Disability Determination
Patients diagnosed with certain blood cancers are now eligible for the Social Security Quick Disability Determination process, ensuring a decision on their cases within just six to eight days.The Compassionate Allowance Initiative...
|
|
|
2. Personalized Anti-Cancer Vaccine, BiovaxID[R], Targeting B-cell Lymphomas
Biovest and idis Partner to Facilitate Patient Access to Lymphoma Vaccine Phase III Study Results to Be Presented at 'Best of ASCO' in Paris TAMPA, Fla.-- Biovest International, Inc. (Other OTC:BVTI), a majority-owned subsidiary...
|
|
|
Yaupon Completes Patient Enrollment For Phase-II Study Of Clearazide
Clearazide, for the treatment of Cutaneous T-cell Lymphoma Yaupon has completed enrollment for a pivotal phase-II clinical trial for Clearazide, for the treatment of early-stage cutaneous T-cell lymphoma (CTCL -...
|
|
|
Bio-Matrix Scientific Group Targets Hospitals Needing Cord Blood Storage
Bio-Matrix Scientific Group, Inc.(OTCBB:BMSN), a San Diego-based biotechnology company, announced today the launch of a national marketing program aimed at hospitals in need of storing umbilical cord blood specimens for future...
|
|
|
A story of cancer, canines and collaboration
RALEIGH, N.C.-With focus on the proverbial man's best friend, researchers from the and its neighbor, the , are combining their expertise to pinpoint the cause of non-Hodgkin lymphoma in humans and canines.The animal and human docs...
|
|
|
Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
According to the American Cancer Society [ACS], non-Hodgkin lymphoma [also known as non-Hodgkins lymphoma, NHL, or sometimes just lymphoma] is a cancer that starts in cells of the lymph system, which is part of the...
|
|
|
BiovaxID Now Available In Europe
BiovaxID, a therapeutic anti-cancer vaccine produced by Biovest, a subsidiary of Accentia Biopharmaceuticals, is now available in Europe.BiovaxID is a personalised vaccine, which uses the patient's own immune system to treat follicular...
|
|
|
Pipeline Online Updates
What company is advancing in cancer immunotherapy?Who just announced a new Phase 3 study in patients with advanced inoperable breast cancer? What drug missed its goal in a mid-stage study of acute myelogenous leukemia (AML)? These are...
|
|
|
Ill. cancer researcher wins $500K genetics prize
Local News, Weather, Traffic, Sports, Stocks, Movies on your Cell Phone More>> NOW!You can have access to the latest News and Weather always on your desktop More>> CHICAGO (AP) - An 84-year-old University...
|
|
|
Damon Runyon Cancer Research Foundation Awards $2.7M To 7 Top Young Clinical Investigators
The Damon Runyon Cancer Research Foundation named 4 new Damon Runyon Clinical Investigators at its April 2009 Clinical Investigator Award Committee review.The recipients of this prestigious, three-year award are outstanding early career...
|
|
|
Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize
New York, NY Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics and a renowned leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation.She is being honored with...
|
|
|
Ill. cancer researcher wins $500K genetics prize (AP)
Play Video Cancer Video:Vegetarians 'avoid more cancers' BBC Play Video Cancer Video:NYU Finds Common Gene In Deadly Cancer Patients CBS 2 New York Play Video Cancer Video:Lemonade Stand Raises Money To Fight Cancer CBS4 Denver 1 hr 1 min...
|
|
|
Ill. cancer researcher wins $500K genetics prize
Play Video Cancer Video:Vegetarians 'avoid more cancers' BBC Play Video Cancer Video:NYU Finds Common Gene In Deadly Cancer Patients CBS 2 New York Play Video Cancer Video:Lemonade Stand Raises Money To Fight Cancer CBS4 Denver 25 mins ago...
|
